BSE Live
May 18, 16:00Prev. Close
3.40
Open Price
3.72
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Key Financial Ratios of Venkat Pharma (in Rs. Cr.) | Mar 14 | Mar 13 | Mar 12 | Mar 11 | Mar 10 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | -0.03 | -0.09 | -0.07 | -0.13 | -0.51 | |
Diluted EPS (Rs.) | -0.03 | -0.09 | -0.07 | -0.13 | -0.51 | |
Cash EPS (Rs.) | -0.03 | -0.06 | -0.04 | -0.08 | -0.42 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 10.00 | -5.09 | -5.00 | -4.93 | -4.80 | |
Book Value [InclRevalReserve]/Share (Rs.) | 10.00 | -5.09 | -5.00 | -4.93 | -4.80 | |
Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
PBDIT/Share (Rs.) | -0.03 | -0.06 | -0.04 | -0.08 | -0.41 | |
PBIT/Share (Rs.) | -0.03 | -0.09 | -0.07 | -0.13 | -0.49 | |
PBT/Share (Rs.) | -0.03 | -0.09 | -0.07 | -0.13 | -0.49 | |
Net Profit/Share (Rs.) | -0.03 | -0.09 | -0.07 | -0.13 | -0.51 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
PBT Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Return on Networth / Equity (%) | -0.30 | 1.74 | 1.46 | 2.59 | 10.59 | |
Return on Capital Employed (%) | -0.06 | -0.26 | -0.21 | -0.46 | -1.83 | |
Return on Assets (%) | -0.06 | -0.24 | -0.20 | -0.35 | -1.38 | |
Total Debt/Equity (X) | 3.86 | -7.57 | -7.70 | -6.59 | -6.76 | |
Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 18.23 | 12.77 | 12.08 | 3.90 | 3.85 | |
Quick Ratio (X) | 16.72 | 11.25 | 10.57 | 3.41 | 3.37 | |
Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 20.04 | 20.46 | 20.39 | 17.83 | 18.57 | |
EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EV/EBITDA (X) | -1,318.47 | -726.97 | -1,165.84 | -451.11 | -90.42 | |
MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 0.16 | -0.49 | -0.48 | -0.68 | -1.00 | |
Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield | -0.02 | -0.04 | -0.03 | -0.04 | -0.11 |